Share Issue News

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV” or the “Company”) (NYSE: BKV) today announced that it has launched an underwritten public offering of 9,692,089 shares of its common stock (the “Offering”), which includes 5,550,000 shares being offered by the Company and 4,142,089 shares being offered by Bedrock Energy Partners, LLC (the “selling stockholder”). BKV expects to grant the underwriter a 30-day option to purchase up to an additional 1,453,813 shares of BKV common stock on the same ter...

SAN FRANCISCO--(BUSINESS WIRE)--Backblaze, Inc. (Nasdaq: BLZE) today announced that on March 10, 2026, it granted an equity inducement award to Dan Spraggins, the Company’s Senior Vice President of Engineering, as a material inducement to Mr. Spraggins’ employment with the Company. The Company’s Board of Directors has also designated Mr. Spraggins as an officer subject to the Section 16 of the Securities Exchange Act of 1934. Mr. Spraggins joined Backblaze in January 2026 as Senior Vice Preside...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase a total of 17,050 shares of the Company’s common stock at an exercise price per share of $23.43, which was th...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of (i) options to purchase an aggregate of 134,540 common shares of the Company (the "Options") and (ii) 34,500 performance share units...

NEW YORK--(BUSINESS WIRE)--Fortress Value Acquisition Corp. V (NASDAQ: FVAV) (www.fortressvalueac5.com) (the “Company”), today announced that the underwriter, pursuant to the terms of the underwriting agreement, exercised in full its previously announced option to purchase up to 3,750,000 newly issued Class A ordinary shares to cover over-allotments, generating additional gross proceeds of $37,500,000. Following the full exercise of the over-allotment option, the total aggregate issuance by the...

DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) is pleased to announce the closing of its previously announced underwritten public offering of 17,940,000 of its common shares, which includes the full exercise of the underwriters’ option to purchase 2,340,000 additional common shares, at a price to the public of US$2.50 per share. The total gross proceeds to Vista were US$44.85 million, before deducting underwriting discounts and commission and o...

RICHMOND, Va.--(BUSINESS WIRE)--ASGN Incorporated (NYSE: ASGN), a leading provider of IT solutions across the commercial and government sectors, soon to be renamed Everforth, announced today the successful closing of its previously announced acquisition of Quinnox Inc. (“Quinnox”). Quinnox’s global team will join ASGN’s Commercial Segment. “We are excited to announce the successful closing of our acquisition of Quinnox,” said ASGN's Chief Executive Officer, Ted Hanson. “This strategic platform...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointment of Dale Hooks as Chief Commercial Officer. Mr. Hooks joins the company with nearly 35 years of pharmaceutical marketing and sales experience, including commercial leadership roles for 21 new product launches. Mr. Hooks...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a developer and operator of upscale live music venues and premium hospitality destinations, today announced the pricing of an underwritten public offering of 18,750,000 shares of common stock (or pre-funded warrants (“Pre-Funded Warrant”) in lieu thereof) and one accompanying warrant per share of common stock or Pre-Funded Warrant (“Warrant”). Each share of common stock or Pre-Fun...

LONDON--(BUSINESS WIRE)--Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not c...